This is a randomised controlled pilot study evaluating and assessing the feasibility of a co-designed PET. The PET was co-designed in the qualitative work packages with members of the community as well as healthcare professionals (Ethical approval: REF QMERC22.266) that precedes this pilot trial. Eligible patients from six GP practises from Tower Hamlets and Newham will be randomised to the intervention or control during the study.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The primary outcome is vaccination uptake in patients individually randomised.
Timeframe: Through study completion, until 6 months follow-up (>180 days since randomisation).